Furthermore, the primary pre-B ALL cells with lower expression of IRS1 (Figure 4A–4G) were more sensitive to GZD824 treatment in xenografts (Supplementary Figure S4). This evidence concerns the gene IRS1 and acute lymphoblastic leukemia.